Mani Subramanian, CEO

Professional Overview

Mani Subramanian is a seasoned biotechnology executive with over 20 years of experience leading research and development initiatives in the pharmaceutical and life sciences industries. As the CEO of OrsoBio, he is responsible for driving the company's strategic vision, overseeing all business operations, and fostering a culture of innovation and collaboration.

Experience Summary

Current Role

As the CEO of OrsoBio since April 2020, Mani is spearheading the company's efforts to develop novel therapeutics for the treatment of liver diseases. Under his leadership, OrsoBio has secured several significant partnerships and expanded its pipeline of promising drug candidates. Mani's unwavering commitment to scientific excellence and his ability to navigate complex regulatory landscapes have been instrumental in positioning OrsoBio as a leader in the field of liver disease research.

Career Progression

Prior to joining OrsoBio, Mani held various leadership roles at prominent biopharmaceutical companies. He served as the Senior Vice President and Liver Diseases Therapeutic Area Head at Gilead Sciences, where he oversaw the development and commercialization of groundbreaking therapies for hepatitis C and other liver conditions. Before that, Mani held the position of Executive Director of Clinical Research in Infectious Diseases and Immunology at Human Genome Sciences, where he played a pivotal role in advancing several late-stage drug candidates. Earlier in his career, he served as a Senior Staff Scientist at Celera Corporation, contributing to the company's cutting-edge research in genomics and personalized medicine.

Academic Background

Mani holds a Ph.D. in Molecular Biology from the Massachusetts Institute of Technology (MIT), where he specialized in the study of gene expression and regulation. His extensive academic training and research experience have equipped him with a deep understanding of the underlying science and a strong foundation in translational research.

Areas of Expertise

Mani's areas of expertise span drug discovery, clinical development, and regulatory strategy in the fields of liver diseases, infectious diseases, and immunology. He is a recognized expert in the design and execution of complex clinical trials, with a proven track record of successfully navigating the regulatory landscape to bring innovative therapies to market. Additionally, Mani is an accomplished leader, skilled in building and leading high-performing teams, fostering cross-functional collaboration, and driving organizational transformation.

Professional Impact

Throughout his career, Mani has made significant contributions to the advancement of medical science and the development of life-changing treatments. His work has led to the approval of several new therapies for the management of chronic liver diseases, improving patient outcomes and quality of life. Mani is also an active member of several industry associations and advisory boards, where he shares his expertise and contributes to the ongoing evolution of the biopharmaceutical industry.

Conclusion

Mani Subramanian's exceptional leadership, deep scientific expertise, and unwavering commitment to innovation make him a valuable asset to the biotechnology industry. As the CEO of OrsoBio, he is poised to further drive the company's growth and positively impact the lives of patients suffering from liver diseases.